Healthcare -
Biotechnology - NASDAQ - US
$ 54.4243
4.44 %
$ 3.37 B
Market Cap
69.0
P/E
PTGX - OPERATING INCOME
Operating Income PTGX - Protagonist Therapeutics, Inc.
253 M
LAST VALUE
98.11%
2 YEAR CAGR
38.74%
5 YEAR CAGR
40.10%
10 YEAR CAGR